Skip to search formSkip to main contentSkip to account menu

OPC 8490

Known as: OPC-8490, Piperazine, 1-(4-oxo-4-phenylbutyl)-4-((1,2,3,4-tetrahydro-2-oxo-6-quinolinyl)carbonyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
SummaryOPC-8490 [3,4-dihydro-6-[4-(4-oxo-4-phenylbutyl)-1-piperazinylcarbonyl]-2(1H)-quinolinone citrate] elicited a positive… 
1996
1996
BACKGROUND The quinolinone compounds OPC-8212 (vesnarinone), OPC-18790, and OPC-8490 are members of a family of unique positive… 
1991
1991
Whether beneficial hemodynamic effects of cardiovascular drugs are due to changes in the inotropic or loading conditions has been… 
1990
1990
SummaryThe direct actions of OPC-8490 on mammalian myocardium were examined by determination of the drug's effects on the action… 
1990
1990
SummaryTo elucidate the ionic mechanisms underlying prolongation of the action potential by OPC-8490, a novel positive inotropic… 
Review
1989
Review
1989
New positive inotropic agents have been synthesized and they are under intensive research to examine whether they are different…